BREAKYL

This brand name is authorized in Estonia, France, Lithuania, Poland, Spain.

Active ingredients

The drug BREAKYL contains one active pharmaceutical ingredient (API):

1	Fentanyl UNII MUN5LYG46H - FENTANYL CITRATE
	Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.
	Read more about Fentanyl

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AB03	Fentanyl	N Nervous system → N02 Analgesics → N02A Opioids → N02AB Phenylpiperidine derivatives
Discover more medicines within N02AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1344057, 1344091, 1514034, 1537826, 1537837, 1537848, 1537859, 1537860, 1537871, 1537882, 1537893, 1555107, 1555118, 1555129, 1586796, 1586842, 1586897
ES	Centro de información online de medicamentos de la AEMPS	74146, 74147, 74148, 74149, 74150
FR	Base de données publique des médicaments	61300005, 67194854
LT	Valstybinė vaistų kontrolės tarnyba	1031783, 1060967, 1064718, 1064719, 1064720, 1064721, 1064722, 1064723, 1064724, 1064725, 1064726, 1064727, 1064728, 1064729, 1064730, 1064731
PL	Rejestru Produktów Leczniczych	100248553, 100248576, 100248582, 100248599, 100249788